Earnings Call · Q1 FY2026·2026-05-05

Q1 26EPS -22.89%·Rev n/aQ4 25EPS +19.09%·Rev n/aQ3 25EPS +1.55%·Rev n/aQ2 25EPS +100.00%·Rev n/a⚠ consensus missing

Arcus Biosciences, Inc. RCUS

Holli Kolkey — Investor Relations or Communications

Terry Rosen — Chief Executive Officer

Richard Markus — Chief Medical Officer

Juan Jaen — President

Robert Goeltz — Chief Financial Officer

−0.2%1d on move date−1.6% vs SPY3d−2.7%5d−4.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCUS calls or request research access.

More RCUS calls Browse calls Request research access